参考文献/References:
[1]SILBERGLEIT AK, SCHULTZ L, HAMILTON K, et al. Self-perception of voice and swallowing handicap in Parkinson's disease [J]. J Parkinsons Dis, 2021, 11(4): 2027-2034.
[2]POLYCHRONIS S, NICCOLINI F, PAGANO G, et al. Speech difficulties in early de novo patients with Parkinson's disease [J]. Parkinsonism Relat Disord, 2019, 64: 256-261.
[3]JOHARI K, BEHROOZMAND R. Neural correlates of speech and limb motor timing deficits revealed by aberrant beta band desynchronization in Parkinson's disease [J]. Clin Neurophysiol, 2021, 132(10): 2711-2721.
[4]HAMID E, AYELE BA, MASSI D G, et al. Availability of therapies and services for Parkinson's disease in Africa: a continent-wide survey [J]. Mov Disord, 2021, 36(10): 2393-2407.
[5]SAPIR S. Multiple factors are involved in the dysarthria associated with Parkinson's disease: a review with implications for clinical practice and research [J]. J Speech, Lang Hear Res, 2014, 57(4): 1330-1343.
[6]NOREL R, AGURTO C, HEISIG S, et al. Speech-based characterization of dopamine replacement therapy in people with Parkinson's disease [J]. NPJ Parkinsons Dis, 2020, 6: 12.
[7]MAGEE M, COPLAND D, VOGEL AP. Motor speech and nonmotor language endophenotypes of Parkinson's disease [J]. Expert Rev Neurother, 2019, 19(12): 1191-1200.
[8]HANSON DG, GERRATT BR, WARD PH. Cinegraphic observations of laryngeal function in Parkinson's disease [J]. Laryngoscope, 1984, 94(3): 348-353.
[9]VAN HOOREN MR, BAIJENS LW, VOS R, et al. Voice- and swallow-related quality of life in idiopathic Parkinson's disease [J]. Laryngoscope, 2016, 126(2): 408-414.
[10]NOVOTNY M, TYKALOVA T, RUZICKOVA H, et al. Automated video-based assessment of facial bradykinesia in de-novo Parkinson's disease [J]. NPJ Digit Med, 2022, 5(1): 98.
[11]MOREAU C, PINTO S. Misconceptions about speech impairment in Parkinson's disease [J]. Mov Disord, 2019, 34(10): 1471-1475.
[12]DOCU AXELERAD A, STROE AZ, ARGHIR OC, et al. Respiratory dysfunctions in Parkinson's disease patients [J]. Brain Sci, 2021, 11 (5): 258.
[13]HOIT JD, LANSING RW, BROWN VP, et al. Speaking dyspnea in Parkinson's disease: preliminary findings [J]. J Commun Disord, 2020, 88: 106050.
[14]DAOUDI K, DAS B, TYKALOVA T, et al. Speech acoustic indices for differential diagnosis between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy [J]. NPJ Parkinsons Dis, 2022, 8(1): 142.
[15]LIOTTI M, RAMIG LO, VOGEL D, et al. Hypophonia in Parkinson's disease: neural correlates of voice treatment revealed by PET [J]. Neurology, 2003, 60(3): 432-440.
[16]BOTHA H, UTIANSKI RL, WHITWELL JL, et al. Disrupted functional connectivity in primary progressive apraxia of speech [J]. Neuroimage Clin, 2018, 18: 617-629.
[17]SKODDA S, VISSER W, SCHLEGEL U. Vowel articulation in Parkinson's disease [J]. J Voice, 2011, 25(4): 467-472.
[18]VIZZA P, TRADIGO G, MIRARCHI D, et al. Methodologies of speech analysis for neurodegenerative diseases evaluation [J]. Int J Med Inform, 2019, 122: 45-54.
[19]BARNISH MS, HORTON SMC, BUTTERFINT ZR, et al. Speech and communication in Parkinson's disease: a cross-sectional exploratory study in the UK [J]. BMJ Open, 2017, 7(5): e014642.
[20]ARMSTRONG M J, OKUN MS. Diagnosis and Treatment of Parkinson disease: a review [J]. JAMA, 2020, 323(6): 548-560.
[21]REICH SG, SAVITT JM. Parkinson's disease [J]. Med Clin North Am, 2019, 103(2): 337-350.
[22]SKODDA S, RINSCHE H, SCHLEGEL U. Progression of dysprosody in Parkinson's disease over time--a longitudinal study [J]. Mov Disord, 2009, 24(5): 716-722.
[23]VASQUEZ-CORRE A, ARIAS-VERGAR A, OROZCO-ARROYA V, et al. Multimodal assessment of Parkinson's disease: a deep learning approach [J]. IEEE J Biomed Health Inform, 2019, 23(4): 1618-1630.
[24]RIGRODSKY S, MORRISON EB. Speech changes in parkinsonism during L-dopa therapy: preliminary findings [J]. J Am Geriatr Soc, 1970, 18(2): 142-151.
[25]LECHIEN JR, DELSAUT B, ABDERRAKIB A, et al. Orofacial strength and voice quality as outcome of levodopa challenge test in Parkinson disease [J]. Laryngoscope, 2020, 130(12): E896-E903.
[26]FOX SH, KATZENSCHLAGER R, LIM SY, et al. International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson's disease [J]. Mov Disord, 2018, 33(8): 1248-1266.
[27]YUAN F, GUO X, WEI X, et al. Lee Silverman voice treatment for dysarthria in patients with Parkinson's disease: a systematic review and meta-analysis [J]. Eur J Neurol, 2020, 27(10): 1957-1970.
[28]PU T, HUANG M, KONG X, et al. Lee Silverman voice treatment to improve speech in Parkinson's disease: a systemic review and metaanalysis [J]. Parkinsons Dis, 2021, 2021: 3366870.
[29]BRABENEC L, KLOBUSIAKOVA P, SIMKO P, et al. Non-invasive brain stimulation for speech in Parkinson's disease: a randomized controlled trial [J]. Brain Stimul, 2021, 14(3): 571-578.
[30]FABBRI M, NATALE F, ARTUSI CA, et al. Deep brain stimulation fine-tuning in Parkinson's disease: short pulse width effect on speech [J]. Parkinsonism Relat Disord, 2021, 87: 130-134.
[31]ZIBETTI M, MORO E, KRISHNA V, et al. Low-frequency subthalamic stimulation in Parkinson's disease: long-term outcome and predictors [J]. Brain Stimul, 2016, 9(5): 774-779.
相似文献/References:
[1]张 威 李 楠 张海红 马 磊 高金鉴 王学廉 高国栋.丘脑底核与苍白球内侧部电刺激术治疗帕金森病疗效的Meta分析[J].中国临床神经外科杂志,2015,(12):718.[doi:10.13798/j.issn.1009-153X.2015.12.005]
ZHANG Wei,LI Nan,ZHANG Hai-hong,et al.Meta-analysis of curative effects of electric stimulation of the globus pallidus and subthalamic nucleus on Parkinson disease[J].,2015,(04):718.[doi:10.13798/j.issn.1009-153X.2015.12.005]
[2]欧阳佳 武广永 综述 刘如恩 审校.帕金森病基因治疗研究进展[J].中国临床神经外科杂志,2015,(03):187.[doi:10.13798/j.issn.1009-153X.2015.03.022]
[3]管得宁,张 扬,徐 运.帕金森病的发病机制及治疗研究进展[J].中国临床神经外科杂志,2016,(11):732.[doi:10.13798/j.issn.1009-153X.2016.11.031]
[4]陈礼道 柳 雯 张 捷 付 锴 张继波 刘学猛 彭启珍 丁 伟.脂质头皮标志物在脑深部电刺激术针道设计中的应用[J].中国临床神经外科杂志,2017,(09):619.[doi:10.13798/j.issn.1009-153X.2017.09.004]
CHEN Li-dao,LIU Wen,ZHANG Jie,et al.Application of lipid scalp markers to the design of electrode track for deep brain stimulation in patients with movement disorders[J].,2017,(04):619.[doi:10.13798/j.issn.1009-153X.2017.09.004]
[5]陈宇昆 综述 王学廉 审校.脑深部电刺激术治疗帕金森病新进展[J].中国临床神经外科杂志,2018,(01):56.[doi:10.13798/j.issn.1009-153X.2018.01.024]
[6]陈礼道 综述 张 捷 审校.帕金森病脑深部电刺激术后程控策略[J].中国临床神经外科杂志,2018,(07):506.[doi:10.13798/j.issn.1009-153X.2018.07.021]
[7]姜 磊 邵 华 王西宪 石 鑫 冯兆海 郝玉军.丘脑底核电刺激术治疗帕金森病的疗效观察[J].中国临床神经外科杂志,2019,(01):13.[doi:10.13798/j.issn.1009-153X.2019.01.003]
JIANG Lei,SHAO Hua,WANG Xi-xian,et al.Curative effect of deep brain stimulation of subthalamic nucleus on Parkinson’s disease[J].,2019,(04):13.[doi:10.13798/j.issn.1009-153X.2019.01.003]
[8]张建英 马立山.DBS对帕金森病病人精神症状及认知功能的影响[J].中国临床神经外科杂志,2020,(10):703.[doi:10.13798/j.issn.1009-153X.2020.10.014]
[9]郭 松 任志伟 胡永生等.单纯影像定位与微电极辅助定位在帕金森病手术中的应用[J].中国临床神经外科杂志,2021,26(03):149.[doi:10.13798/j.issn.1009-153X.2021.03.002]
GUO Song,REN Zhi-wei,HU Yong-sheng,et al.Simple imaging-guided versus microelectrode recording-guided deep brain stimulaton for patients with Parkinson’s disease[J].,2021,26(04):149.[doi:10.13798/j.issn.1009-153X.2021.03.002]
[10]蒋 伟 郐国虎 刘魏华等.双侧丘脑底核脑深部电刺激术治疗帕金森病的疗效分析[J].中国临床神经外科杂志,2021,26(10):755.[doi:10.13798/j.issn.1009-153X.2021.10.004]
JIANG Wei,KUAI Guo-hu,LIU Wei-hua,et al.Clinical efficacy of bilateral subthalamic nucleus deep brain stimulation for patients with Parkinson’s disease[J].,2021,26(04):755.[doi:10.13798/j.issn.1009-153X.2021.10.004]